Lv4
710 积分 2025-10-09 加入
Can we consider stopping hepatocellular carcinoma surveillance in low-risk patients with hepatitis B?
2天前
已完结
Prospects for leveraging knowledge on ISG and NF-kB effector functions into anti-HBV therapies
10天前
已关闭
Epigenetic Modifications in HBV‐Related Hepatocellular Carcinoma
17天前
已完结
The APOBEC3 family: a narrative review of an alternative therapeutic agent for hepatitis B virus-induced hepatocellular carcinoma
21天前
已完结
Interferons in health and disease
28天前
已完结
Type I interferons in health and disease: molecular aspects and clinical implications
28天前
已完结
Current evidence of bulevirtide as monotherapy compared to combination treatment with pegylated interferon for hepatitis delta
30天前
已完结
Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection
1个月前
已完结
HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications
1个月前
已完结
Global disparities in liver cancer burden: an epidemiological and socioeconomic analysis using GBD 1990–2021 data
1个月前
已完结
皖公网安备34019202002308
